CDiddy,

Thanks. Look forward to the update. I would very much like to know this info.

But reminds me that mono is a quality of life issue, Covid is a life and death issue, and we have a production problem. Probably why tracking the 2b/3 in Mono has gone quiet.

“Our phase 2b/3 trial for monotherapy began in August of 2016. I am unsure where we are at enrollment wise I am embarrassed to say. Ill see if I can find anything.”